Is Victory in Sight?
Covid-19 vaccine rolled out
An outcome of joint research efforts by an American pharmaceutical giant and a German biotechnology company, Pfizer-BioNTech Covid-19 vaccine got an emergency use authorization (EUA) from the Food and Drug Administration (FDA) of the US on 11 December for the prevention of Covid-19 in individuals 16 years of age and older. This EUA allowed the Pfizer-BioNTech Covid-19 vaccine to be distributed in the United States. The vaccine authorization is being considered by many as a step which can “alter the course of the pandemic” in spite of the fact that EUA is not an approval, and is issued by the FDA in an emergency when there are no adequate approved or available options for treatment of life-threatening diseases. This implies that the needed evidence for a full FDA approval of the Pfizer-BioNTech Covid-19 vaccine is still not there.
Sorry you have no rights to view this Article/Post!
Please Login or Register to view the complete Article
To get full access EMAIL your username, Subscription Plan and email address at email@example.com for details or Whatsapp on
0302 555 68 02
Rs. 3500 for 1 year.